Featured Publications
In the balance: No new diagnosis needed in addition to opioid use disorder to study harms associated with long‐term opioid therapy
Drexler K, Edens E, Trafton J, Compton W. In the balance: No new diagnosis needed in addition to opioid use disorder to study harms associated with long‐term opioid therapy. Addiction 2023, 119: 6-8. PMID: 37766392, DOI: 10.1111/add.16349.Peer-Reviewed Original ResearchWhat Role Should Psychiatrists Have in Responding to the Opioid Epidemic?
Muvvala SB, Edens EL, Petrakis IL. What Role Should Psychiatrists Have in Responding to the Opioid Epidemic? JAMA Psychiatry 2019, 76: 107-108. PMID: 30484813, DOI: 10.1001/jamapsychiatry.2018.3123.Peer-Reviewed Original Research
2023
Perioperative Management of Extended-Release Buprenorphine: A Narrative Review and Case Series
Hickey T, Meeks T, Oxentine H, Park D, Abelleira A, Edens E, Gordon A, Acampora G. Perioperative Management of Extended-Release Buprenorphine: A Narrative Review and Case Series. Substance Abuse 2023, 44: 96-103. PMID: 37226900, DOI: 10.1177/08897077231167043.Peer-Reviewed Original ResearchConceptsExtended-release buprenorphinePerioperative managementPerioperative experienceNarrative reviewOutpatient inguinal hernia repairFull agonist opioidsSeries of patientsOpioid use disorderCases of patientsCommon clinical challengeInguinal hernia repairVariety of surgeriesDifferent medical centersDisorder treatment providersNationwide healthcare systemMultimodal analgesiaAgonist opioidsCase seriesBuprenorphine formulationsInpatient surgeryCase reportProspective dataClinical dataHernia repairClinical challenge
2022
Perioperative Management of Extended-release Buprenorphine
Hickey TR, Henry JT, Edens EL, Gordon AJ, Acampora G. Perioperative Management of Extended-release Buprenorphine. Journal Of Addiction Medicine 2022, 17: e67-e71. PMID: 35862898, DOI: 10.1097/adm.0000000000001024.Peer-Reviewed Original ResearchMeSH KeywordsAnalgesics, OpioidBuprenorphineDelayed-Action PreparationsHumansOpioid-Related DisordersPainPain Management
2021
Optimizing Interdisciplinary Virtual Pain Care and Buprenorphine Initiation During COVID-19: A Quality Improvement Study
Edmond SN, Currie S, Gehrke A, Falker CG, Sung M, Abelleira A, Edens EL, Becker WC. Optimizing Interdisciplinary Virtual Pain Care and Buprenorphine Initiation During COVID-19: A Quality Improvement Study. Pain Medicine 2021, 23: 1043-1046. PMID: 34940877, PMCID: PMC9383145, DOI: 10.1093/pm/pnab348.Peer-Reviewed Original Research
2020
Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series.
Becker WC, Frank JW, Edens EL. Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series. Annals Of Internal Medicine 2020, 173: 70-71. PMID: 32252072, DOI: 10.7326/l19-0725.Peer-Reviewed Original Research
2018
Multimodal Treatment Options, Including Rotating to Buprenorphine, Within a Multidisciplinary Pain Clinic for Patients on Risky Opioid Regimens: A Quality Improvement Study
Oldfield BJ, Edens EL, Agnoli A, Bone CW, Cervone DJ, Edmond SN, Manhapra A, Sellinger JJ, Becker WC. Multimodal Treatment Options, Including Rotating to Buprenorphine, Within a Multidisciplinary Pain Clinic for Patients on Risky Opioid Regimens: A Quality Improvement Study. Pain Medicine 2018, 19: s38-s45. PMID: 30203007, DOI: 10.1093/pm/pny086.Peer-Reviewed Original ResearchConceptsPrimary care providersIntake appointmentMorphine equivalent daily dosePartial opioid agonist buprenorphineVeterans Health Administration hospitalsPartial agonist therapiesPrescribed opioid dosesRetrospective cohort studyUnsafe useEquivalent daily doseMultidisciplinary pain clinicMultimodal treatment optionsChronic pain managementPrimary care settingQuality improvement studyHealth system levelHealth system improvementOpioid dosesCohort studyPain clinicDaily doseOpioid regimensPain managementMultidisciplinary clinicTreatment options
2017
Patient and Public Safety Maximized by Rapid Opioid Taper—Reply
Guillod P, Edens EL, Becker WC. Patient and Public Safety Maximized by Rapid Opioid Taper—Reply. JAMA Internal Medicine 2017, 177: 896-896. PMID: 28586812, DOI: 10.1001/jamainternmed.2017.1454.Peer-Reviewed Original Research